Quantitative electroencephalographic subtyping of obsessive-compulsive disorder

[1]  B. Pacella,et al.  CLINICAL AND EEG STUDIES IN OBSESSIVE-COMPULSIVE STATES , 1944 .

[2]  D. Simons,et al.  The electroencephalogram and personality organization in the obsessive-compulsive reactions. , 1947, Archives of neurology and psychiatry.

[3]  Z. Koles,et al.  Neuropsychological and power spectral EEG investigations of the obsessive-compulsive syndrome. , 1979, Biological psychiatry.

[4]  T. Insel,et al.  Neurological and neuropsychological studies of patients with obsessive-compulsive disorder. , 1983, Biological psychiatry.

[5]  J L Rapoport,et al.  Computerized tomography and neuropsychological test measures in adolescents with obsessive-compulsive disorder. , 1984, The American journal of psychiatry.

[6]  M. Jenike,et al.  The EEG in obsessive-compulsive disorder. , 1984, The Journal of clinical psychiatry.

[7]  Conners Ck,et al.  Rating scales and checklists for child psychopharmacology. , 1985 .

[8]  B. Saletu,et al.  Classification and determination of cerebral bioavailability of fluoxetine: pharmacokinetic, pharmaco-EEG, and psychometric analyses. , 1985, The Journal of clinical psychiatry.

[9]  D. Beidel,et al.  Fluoxetine treatment of obsessive-compulsive disorder. , 1985, Journal of clinical psychopharmacology.

[10]  L. Siever,et al.  Tricyclic response in obsessive compulsive disorder , 1985, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

[11]  G. Chouinard,et al.  Fluoxetine in the treatment of obsessive compulsive disorder , 1985, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

[12]  Trimipramine in the treatment of obsessive-compulsive disorder. , 1987 .

[13]  T. Insel,et al.  Drug treatment of obsessive-compulsive disorder. , 1987, Journal of affective disorders.

[14]  J. Mazziotta,et al.  Local cerebral glucose metabolic rates in obsessive-compulsive disorder. A comparison with rates in unipolar depression and in normal controls. , 1987, Archives of general psychiatry.

[15]  S. Khanna.  Obsessive-compulsive disorder: Is there a frontal lobe dysfunction? , 1988, Biological Psychiatry.

[16]  D. Sheehan,et al.  The potential role of serotonin reuptake inhibitors in the treatment of obsessive compulsive disorder. , 1988, The Journal of clinical psychiatry.

[17]  E. Hollander,et al.  Fluoxetine treatment of obsessive-compulsive disorder: an open clinical trial. , 1989, Journal of clinical psychopharmacology.

[18]  W. Goodman,et al.  Efficacy of fluvoxamine in obsessive-compulsive disorder. A double-blind comparison with placebo. , 1989, Archives of general psychiatry.

[19]  W. Goodman,et al.  The Yale-Brown Obsessive Compulsive Scale. II. Validity. , 1989, Archives of general psychiatry.

[20]  E. Hollander,et al.  Biological Aspects of Obsessive Compulsive Disorder , 1989 .

[21]  J. Rapoport,et al.  High prevalence of obsessive-compulsive symptoms in patients with Sydenham's chorea. , 1989, The American journal of psychiatry.

[22]  T. Nordahl,et al.  Cerebral glucose metabolic rates in obsessive compulsive disorder. , 1989, Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology.

[23]  B Mazoyer,et al.  Obsessive-compulsive and other behavioural changes with bilateral basal ganglia lesions. A neuropsychological, magnetic resonance imaging and positron tomography study. , 1989, Brain : a journal of neurology.

[24]  W. Goodman,et al.  The Yale-Brown Obsessive Compulsive Scale. I. Development, use, and reliability. , 1989, Archives of general psychiatry.

[25]  J. Hoffman,et al.  Long-term fluoxetine treatment of a large number of obsessive-compulsive patients. , 1989, Journal of clinical psychopharmacology.

[26]  L. Baxter.  Brain imaging as a tool in establishing a theory of brain pathology in obsessive compulsive disorder. , 1990, The Journal of clinical psychiatry.

[27]  S. Olson,et al.  Clomipramine in Obsessive‐Compulsive Disorder: Clinical Response and Plasma Levels , 1990, Journal of clinical psychopharmacology.

[28]  W. Goodman,et al.  Clinical predictors of treatment response in obsessive compulsive disorder: exploratory analyses from multicenter trials of clomipramine. , 1990, Psychopharmacology bulletin.

[29]  D. Murphy,et al.  Local cerebral glucose metabolic rates in obsessive-compulsive disorder. Patients treated with clomipramine. , 1990, Archives of general psychiatry.

[30]  E. Hollander,et al.  Signs of central nervous system dysfunction in obsessive-compulsive disorder. , 1990, Archives of general psychiatry.

[31]  J. Krystal,et al.  Specificity of serotonin reuptake inhibitors in the treatment of obsessive-compulsive disorder. Comparison of fluvoxamine and desipramine. , 1990, Archives of general psychiatry.

[32]  A. Syrota,et al.  Obsessive‐compulsive disorder: a clinical, neuropsychological and positron emission tomography study , 1990, Acta psychiatrica Scandinavica.

[33]  J. Deveaugh-Geiss,et al.  Clomipramine in obsessive-compulsive disorder , 1990, Biological Psychiatry.

[34]  R. Hales,et al.  Pharmacologic management of aggression in the elderly. , 1990, The Journal of clinical psychiatry.

[35]  S. Montgomery,et al.  Fluvoxamine in the treatment of obsessive compulsive disorder , 1992, International clinical psychopharmacology.